Differences in the cytogenetic underpinnings of AL amyloidosis among African Americans and Caucasian Americans.
作者信息
Staron Andrew, Zheng Luke, Doros Gheorghe, Sanchorawala Vaishali
机构信息
Amyloidosis Center, Boston University School of Medicine, Boston, MA, USA.
Section of Hematology and Medical Oncology, Boston University School of Medicine and Boston Medical Center, Boston, MA, USA.
出版信息
Blood Cancer J. 2022 Jul 4;12(7):100. doi: 10.1038/s41408-022-00697-3.
Abstract
摘要
相似文献
1
Differences in the cytogenetic underpinnings of AL amyloidosis among African Americans and Caucasian Americans.
Blood Cancer J. 2022 Jul 4;12(7):100. doi: 10.1038/s41408-022-00697-3.
2
Clinical characteristics of African Americans vs Caucasian Americans with multiple sclerosis.
Neurology. 2005 Jun 28;64(12):2163. doi: 10.1212/wnl.64.12.2163.
3
FLG Variation Differs between European Americans and African Americans.
J Invest Dermatol. 2021 Jul;141(7):1855-1857. doi: 10.1016/j.jid.2020.12.022. Epub 2021 Jan 22.
4
Increased prevalence of dihydropyrimidine dehydrogenase deficiency in African-Americans compared with Caucasians.
Clin Cancer Res. 2006 Sep 15;12(18):5491-5. doi: 10.1158/1078-0432.CCR-06-0747.
5
Hepatic gene expression of Caucasian and African-American patients with obesity-related non-alcoholic fatty liver disease.
Obes Surg. 2010 May;20(5):640-50. doi: 10.1007/s11695-010-0078-2. Epub 2010 Jan 30.
6
Reducing colorectal cancer risk among African Americans.
Gastroenterology. 2015 Nov;149(6):1302-4. doi: 10.1053/j.gastro.2015.08.033. Epub 2015 Aug 22.
7
Comparison of germline mutations in African American and Caucasian men with metastatic prostate cancer.
Prostate. 2021 May;81(7):433-439. doi: 10.1002/pros.24123. Epub 2021 Apr 1.
8
In contrast to other stimulatory natural killer cell immunoglobulin-like receptor loci, several KIR2DS5 alleles predominate in African Americans.
Hum Immunol. 2009 Sep;70(9):733-7. doi: 10.1016/j.humimm.2009.04.028. Epub 2009 May 3.
9
Novel locus for atopic dermatitis in African Americans and replication in European Americans.
J Allergy Clin Immunol. 2019 Mar;143(3):1229-1231. doi: 10.1016/j.jaci.2018.10.038. Epub 2018 Nov 9.
10
New genetic variant that might improve warfarin dose prediction in African Americans.
Br J Clin Pharmacol. 2010 Sep;70(3):393-9. doi: 10.1111/j.1365-2125.2010.03709.x.
本文引用的文献
1
Impact of cytogenetic abnormalities on treatment outcomes in patients with amyloid light-chain amyloidosis: subanalyses from the ANDROMEDA study.
Amyloid. 2023 Sep;30(3):268-278. doi: 10.1080/13506129.2022.2164488. Epub 2023 Feb 13.
2
Predictive factors of outcomes in patients with AL amyloidosis treated with daratumumab.
Am J Hematol. 2022 Jan 1;97(1):79-89. doi: 10.1002/ajh.26399. Epub 2021 Nov 15.
3
Effect of t (11;14) Abnormality on Outcomes of Patients With Newly Diagnosed Multiple Myeloma in the Connect MM Registry.
Clin Lymphoma Myeloma Leuk. 2022 Mar;22(3):149-157. doi: 10.1016/j.clml.2021.08.007. Epub 2021 Aug 29.
4
Race/ethnicity in systemic AL amyloidosis: perspectives on disease and outcome disparities.
Blood Cancer J. 2020 Nov 10;10(11):118. doi: 10.1038/s41408-020-00385-0.
5
Presence of t(11;14) in AL amyloidosis as a marker of response when treated with a bortezomib-based regimen.
Amyloid. 2020 Dec;27(4):244-249. doi: 10.1080/13506129.2020.1778461. Epub 2020 Jun 19.
6
A meta-analysis of genome-wide association studies of multiple myeloma among men and women of African ancestry.
Blood Adv. 2020 Jan 14;4(1):181-190. doi: 10.1182/bloodadvances.2019000491.
7
Molecular underpinnings of clinical disparity patterns in African American vs. Caucasian American multiple myeloma patients.
Blood Cancer J. 2019 Feb 4;9(2):15. doi: 10.1038/s41408-019-0177-9.
8
Cytogenetic intraclonal heterogeneity of plasma cell dyscrasia in AL amyloidosis as compared with multiple myeloma.
Blood Adv. 2018 Oct 23;2(20):2607-2618. doi: 10.1182/bloodadvances.2018023200.
9
Differences in genomic abnormalities among African individuals with monoclonal gammopathies using calculated ancestry.
Blood Cancer J. 2018 Oct 10;8(10):96. doi: 10.1038/s41408-018-0132-1.
10
Prognostic impact of cytogenetic aberrations in AL amyloidosis patients after high-dose melphalan: a long-term follow-up study.
Blood. 2016 Jul 28;128(4):594-602. doi: 10.1182/blood-2015-10-676361. Epub 2016 Jun 2.
Zotero 插件